- Home
- RLAY vs CFB Comparison
RLAY vs CFB Comparison
Compare RLAY & CFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- CFB
- Stock Information
- Founded
- RLAY 2015
- CFB 2007
- Country
- RLAY United States
- CFB United States
- Employees
- RLAY N/A
- CFB N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- CFB Major Banks
- Sector
- RLAY Health Care
- CFB Finance
- Exchange
- RLAY Nasdaq
- CFB Nasdaq
- Market Cap
- RLAY 811.8M
- CFB 751.6M
- IPO Year
- RLAY 2020
- CFB 2019
- Fundamental
- Price
- RLAY $3.92
- CFB $16.14
- Analyst Decision
- RLAY Strong Buy
- CFB Strong Buy
- Analyst Count
- RLAY 10
- CFB 3
- Target Price
- RLAY $20.11
- CFB $19.33
- AVG Volume (30 Days)
- RLAY 1.4M
- CFB 228.1K
- Earning Date
- RLAY 02-28-2025
- CFB 04-14-2025
- Dividend Yield
- RLAY N/A
- CFB N/A
- EPS Growth
- RLAY N/A
- CFB 16.42
- EPS
- RLAY N/A
- CFB 1.56
- Revenue
- RLAY $10,006,000.00
- CFB $250,664,000.00
- Revenue This Year
- RLAY N/A
- CFB N/A
- Revenue Next Year
- RLAY N/A
- CFB $4.74
- P/E Ratio
- RLAY N/A
- CFB $10.64
- Revenue Growth
- RLAY N/A
- CFB 8.51
- 52 Week Low
- RLAY $3.50
- CFB $10.64
- 52 Week High
- RLAY $10.89
- CFB $19.22
- Technical
- Relative Strength Index (RSI)
- RLAY 41.60
- CFB 49.96
- Support Level
- RLAY $3.85
- CFB $16.17
- Resistance Level
- RLAY $4.19
- CFB $16.89
- Average True Range (ATR)
- RLAY 0.28
- CFB 0.54
- MACD
- RLAY -0.02
- CFB -0.01
- Stochastic Oscillator
- RLAY 24.80
- CFB 49.07
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About CFB CrossFirst Bankshares Inc.
CrossFirst Bankshares Inc is engaged in providing banking and financial services to businesses, business owners, professionals, and professional networks. The services offered by the company includes Checking accounts, Savings accounts, Personal Loans, International Banking, Business Loans, and Treasury services. The company generates revenue from interest income and fees on loans and interest earned from its marketable securities portfolio.